Canadian intraoperative MRI technology developer IMRIS of Winnipeg, Manitoba, has received clearance from Australia's Therapeutic Goods Administration to market its IMRISNV and IMRIScardio scanners in Australia.
IMRISNV features a wide-bore 3-tesla MRI scanner and a biplane angiography system integrated into a single suite that permits patients being treated for neurovascular disorders to be transitioned between MR imaging and intervention without transporting the patient between modalities.
The IMRIScardio suite includes a wide-bore 1.5-tesla MRI scanner and a single-plane or biplane angiography system to alternate between imaging modalities and assess treatment.
IMRISNV and IMRIScardio also are approved for marketing in Canada, the U.S., and Europe.
Related Reading
IMRIS to acquire NeuroArm Surgical, February 5, 2010
NeuroGrafix claims IMRIS patent infringement, December 21, 2009
IMRIS gets FDA nod, September 8, 2009
IMRIS wins CE Mark for MR angiography suite, May 1, 2009
IMRIS lands China install, April 16, 2009
Copyright © 2010 AuntMinnie.com
.fFmgij6Hin.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&w=100&auto=format%2Ccompress&q=70)
.fFmgij6Hin.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=167&w=250&auto=format%2Ccompress&q=70)
